Massive hope for pancreatic cancer pill after trial saw tumours vanish

A new daily pill called daraxonrasib has shown promising results in early clinical trials for advanced pancreatic cancer, with some patients seeing tumors shrink or become undetectable. While experts caution it is not a cure, it is being hailed as a significant breakthrough for a disease with historically low survival rates.
Why it matters
Pancreatic cancer is notoriously difficult to treat; this drug offers a potential new pathway for extending patient life and improving outcomes.
Image source, Getty Images By Michelle Roberts Digital health editor Published 6 minutes ago Experts are calling it the biggest breakthrough in pancreatic cancer treatment for decades - a daily pill that appears to shrink and possibly even eliminate tumours in some patients with one of the deadliest and hardest-to-treat cancers.
Cancer became undetectable on scans in one in 12 of the patients given daraxonrasib along with chemotherapy in early medical trials.
Tumours stopped growing in almost all of the 61 participants who had recently been diagnosed with advanced pancreatic cancer that had spread to other parts of the body.
But doctors stress it is a long way from knowing how long it might keep the disease at bay and should not be seen as a cure.
Cancer Research UK called it "the biggest leap forward in decades" for pancreatic cancer patients.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in